Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C

Inclusion Criteria: * Hepatitis C patients (high titer, genotype1) Exclusion Criteria: * Patients with autoimmune disorder * Patients with negative HBs antigen * Patients with hepatic cirrhosis, hepatic failure and hepatic cancer * Patients with depression or psychoneurotic disorder